Activation of BV2 microglia by lipopolysaccharide triggers an inflammatory reaction in PC12 cell apoptosis through a toll-like receptor 4-dependent pathway

Cell Stress and Chaperones

Volumn 20, Issue 2, 2015, Pages 321-331

  Dai, Xiao jing ^a   Li, Na ^a   Yu, Le ^a   Chen, Zi yang ^a   Hua, Rong ^b   Qin, Xia ^a   Zhang, Yong Mei ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b 97th Hospital of PLA   (China)

Author keywords

BV2 microglia; Interleukin 1 ; Lipopolysaccharide; PC12 cell; TLR4

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BCL 2; TOLL LIKE RECEPTOR 4; CONDITIONED MEDIUM; POLYMYXIN B; PROTEIN BAX;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IN VITRO STUDY; INFLAMMATION; MICROGLIA; MTT ASSAY; NEUROTOXICITY; NONHUMAN; PC12 CELL LINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL LINE; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHARMACOLOGY; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE; CULTURE MEDIA, CONDITIONED; DOWN-REGULATION; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MICROGLIA; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PC12 CELLS; POLYMYXIN B; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84925535783     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-014-0552-1     Document Type: Article

References (63)

1. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801
2. Aravalli RN, Peterson PK, Lokensgard JR (2007) Toll-like receptors in defense and damage of the central nervous system. J Neuroimmune Pharm 2:297–312
3. Arslan F, Keogh B, McGuirk P et al (2010) TLR2 and TLR4 in ischemia reperfusion injury. Mediat Inflamm 2010:704202
4. Arumugam TV, Okun E, Tang SC et al (2009) Toll-like receptors in ischemia-reperfusion injury. Shock 32:4–16
5. Baron R (2006) Mechanisms of disease: Neuropathic pain-A clinical perspective. Nat Clin Pract Neurol 2:95–106
6. Bechade C, Cantaut-Belarif Y, Bessis A (2013) Microglial control of neuronal activity. Front Cell Neurosci 7:32
7. Bessis A, Bechade C, Bernard D et al (2007) Microglial control of neuronal death and synaptic properties. Glia 55(3):233–238
8. Block ML, Hong J (2005) Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism. Prog Neurobiol 76(2):77–98
9. Brea D, Blanco M, Sobrino T et al (2010) The levels of expression of toll-like receptors 2 and 4 in neutrophils are associated with the prognosis of ischaemic stroke patients. Rev Neurol 52:12–19
10. Chao CC, Hu S, Ehrlich L et al (1995) Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: Involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 9:355–365
11. Coull JA, Beggs S, Boudreau D et al (2005) BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438:1017–1021
12. De Paola M, Mariani A, Biqini P et al (2012) Neuroprotective effects of toll-like receptor 4 antagonism in spinal cord cultures and in a mouse model of motor neuron degeneration. Mol Med 18:971–981
13. Ding BJ, Ma WW, He LL et al (2011) Soybean isoflavone alleviates beta-amyloid 1–42 induced inflammatory response to improve learning and memory ability by down regulation of Toll-like receptor 4 expression and nuclear factor-kappaB activity in rats. Int J Dev Neurosci 29:537–542
14. Esser R, Glienke W, von Briesen H et al (1996) Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. Blood 88:3474–3481
15. Gao HM, Hong JS (2008) Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol 29(8):357–365
16. Gao HM, Liu B, Zhang W et al (2003) Novel anti-inflammatory therapy for Parkinson’s disease. Trends Pharmacol Sci 24(8):395–401
17. Graeber MB (2010) Changing face of microglia. Science 330(6005):783–788
18. Guo H, Jin YX, Ishikawa M et al (1998) Regulation of betachemokine mRNA expression in adult rat astrocytes by lipopolysaccharide, proinflammatory and immunoregulatory cytokines. Scand J Immunol 48:502–508
19. Gustafson-Vickers SL, Lu VB, Lai AY et al (2008) Long-term actions of interleukin-1beta on delay and tonic firing neurons in rat superficial dorsal horn and their relevance to central sensitization. Mol Pain 4:63
20. Hoarau JJ, Krejbich-Trotot P, Jaffar-Bandjee MC et al (2011) Activation and control of CNS innate immune responses in health and diseases: a balancing act finely tuned by neuroimmune regulators (NIReg). CNS Neurol Disord Drug Targets 10(1):25–43
21. Hughes V (2012) Microglia: the constant gardeners. Nature 485(7400):570–572
22. Inoue K, Tsuda M (2009) Microglia and neuropathic pain. Glia 57:1469–1479
23. Johnson GB, Brunn GJ, Platt JL (2003) Activation of mammalian Toll-like receptors by endogenous agonists. Crit Rev Immunol 23:15–44
24. Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13(5):816–825
25. Kawasaki Y, Zhang L, Cheng JK et al (2008) Cytokine mechanisms of central sensitization: Distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 28(20):5189–5194
26. Kilic U, Kilic E, Matter CM et al (2008) TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration. Neurobiol Dis 31(1):33–40
27. Lee S, Vravel NH, Konerth ME et al (2010) CX3CR1 deficiency alters microglial activation and reduces β-amyloid deposition in two Alzheimer's disease mouse models. Am J Pathol 177(5):2552–2562
28. Lehnardt S (2010) Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 58:253–263
29. Lehnardt S, Lachance C, Patrizi S (2002) The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 22(7):2478–2486
30. Lehnardt S, Massillon L, Follett P et al (2003) Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 100:8514–8519
31. Lehnardt S, Schott E, Trimbuch T et al (2008) A vicious cycle involving release of heat shock protein60 from injured cells and activation of toll-Like receptor 4 mediates neurodegeneration in the CNS. Neuroscience 28:2320–2331
32. Liu Y, Walter S (2005) Staqi M, at al: LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain 128(8):1778–1789
33. Liu T, Gao YJ, Ji RR (2012) Emerging role of Toll-like receptors in the control of pain and itch. Neurosci Bull 28(2):131–144
34. Liu T, Jiang CY, Fujita T et al (2013) Enhancement by interleukin-1beta of AMPA and NMDA receptor-mediated currents in adult rat spinal superficial dorsal horn neurons. Mol Pain 9(1):16
35. Lu YC, Yeh WC, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine 42(2):145–151
36. Mao SS, Hua R, Zhao XP et al (2012) Exogenous administration of PACAP alleviates traumatic brain injury in rats through a mechanism involving the TLR4/MyD88/NF-κB pathway. J Neurotrauma 29(10):1941–1959
37. Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1:135–145
38. Medzhitov R (2007) TLR-mediated innate immune recognition. Semin Immunol 19:1–2
39. Miyake K (2007) Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptor. Semin Immunol 19:3–10
40. Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22:240–273
41. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314–1318
42. Panaro MA, Lofrumento DD, Saponaro C et al (2008) Expression of TLR4 and CD14 in the central nervous system (CNS) in a MPTP mouse model of Parkinson's-like disease. Immunopharmacol Immunotoxicol 30:729–740
43. Qin X, Sun ZQ, Dai XJ et al (2012) Toll-like receptor 4 signaling is involved in PACAP-induced neuroprotection in BV2 microglial cells under OGD/reoxygenation. Neurol Res 34:610–615
44. Qin X, Sun ZQ, Zhang XW et al (2013) TLR4 signaling is involved in the protective effect of propofol in BV2 microglia against OGD/reoxygenation. J Physiol Biochem 64(4):707–718
45. Rajagopal N (2008) Inhibition of toll-like receptor signaling in primary murine microglia. J Neuroimmune Pharm 3:5–11
46. Rev P (2011) Physiology of microglia. Physiol Rev 91:461–553
47. Schulz J (2007) Woolf CJ: The neuropathic pain triad: Neurons, immune cells and glia. Nat Neurosci 10:1361–1368
48. Shu HF, Wang BR, Bi H et al (2007) PC12 cells express IL-1 receptor type I and response to IL-1 stimulation. Respir Physiol Neurobiol 157:187–195
49. Smith HS (2010) Activated microglia in nociception. Pain Physicians 13:295–304
50. Surace MJ, Block ML (2012) Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors. Cell Mol Life Sci 69:2409–2427
51. Suter MR, Wen YR, Decosterd I et al (2007) Do glial cells control pain? Neuron Glia Biol 3:255–268
52. Suzumura A (2013) Neuron-Microglia Interaction in Neuroinflammation. Curr Protein Pept Sci 14(1):16–20
53. Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805–820
54. Tanga FY, Nutile-McMenemy N, DeLeo JA (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A 102(16):5856–5861
55. Trang T, Beggs S, Salter MW (2012) ATP receptor gate microglia signaling in neuropathic pain. Exp Neurol 234:354–361
56. Tsuda M, Shigemoto-Mogami Y, Koizumi S et al (2003) P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424:778–783
57. Tsuda M, Tozaki-Saitoh H, Inoue K (2012) Purinergic system, microglia and neuropathic pain. Curr Opin Pharmacol 12:74–79
58. Ulmann L, Hatcher JP, Hughes JP et al (2008) Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. Neuroscience 28:11263–11268
59. Vollmar P, Kullmann JS, Thilo B, Claussen MC, Rothhammer V, Jacobi H, Sellner J, Waak J, Weber SS, Waldenmaier A et al (2009) Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1. FASEB J 23:2478–2489
60. Wang C, Wang MW, Tashiro S et al (2005) IL-1β acts in synergy with endogenous IL-1β in A375-S2 human melanoma cell apoptosis through mitochondrial pathway. J Korean Med Sci 20:555–561
61. Yao L, Kan EM, Lu J et al (2013) Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia. J Neuroinflammation 10:23
62. Ye L, Huang Y, Zhao L et al (2013) IL-1β and TNF-α induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. Neurochemistry 125(6):897–908
63. Zeng KW, Zhang T, Fu H et al (2012) Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-κB signaling pathway in lipopolysaccharide-induced microglia. Eur J Pharmacol 692(1–3):29–37